SLC12A5 and neoplasm: We used our own LUAD tissue microarray containing 92 pairs of LUAD and matched non-tumor tissue samples with clinicopathologic information and long-time follow-up records to evaluate the clinical utility of TWIST1, SLC12A5 and ZFHX4 among the LUAD patients (Table S4).